Payam Benyamini, Ph.D. - Related publications

University of California, Los Angeles, Los Angeles, CA 
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
50 most relevant papers in past 60 days:
Year Citation  Score
2021 Chen J, Mai H, Chen H, Zhou B, Hou J, Jiang DK. Pan-Cancer Analysis Identified as a Potential Biomarker for Multiple Tumor Types. Frontiers in Molecular Biosciences. 8: 693651. PMID 34490347 DOI: 10.3389/fmolb.2021.693651   
2021 Lai H, Cheng X, Liu Q, Luo W, Liu M, Zhang M, Miao J, Ji Z, Lin GN, Song W, Zhang L, Bo J, Yang G, Wang J, Gao WQ. Single-cell RNA sequencing reveals the epithelial cell heterogeneity and invasive subpopulation in human bladder cancer. International Journal of Cancer. PMID 34480339 DOI: 10.1002/ijc.33794   
2021 Pelka K, Hofree M, Chen JH, Sarkizova S, Pirl JD, Jorgji V, Bejnood A, Dionne D, Ge WH, Xu KH, Chao SX, Zollinger DR, Lieb DJ, Reeves JW, Fuhrman CA, et al. Spatially organized multicellular immune hubs in human colorectal cancer. Cell. PMID 34450029 DOI: 10.1016/j.cell.2021.08.003   
2021 Ahn S, Grimes T, Datta S. The Analysis of Gene Expression Data Incorporating Tumor Purity Information. Frontiers in Genetics. 12: 642759. PMID 34497631 DOI: 10.3389/fgene.2021.642759   
2021 Li W, Song P, Zhao M, Gao L, Xie J, You C. BOP1 Used as a Novel Prognostic Marker and Correlated with Tumor Microenvironment in Pan-Cancer. Journal of Oncology. 2021: 3603030. PMID 34603446 DOI: 10.1155/2021/3603030   
2021 Taguchi J, Shibata H, Kabata M, Kato M, Fukuda K, Tanaka A, Ohta S, Ukai T, Mitsunaga K, Yamada Y, Nagaoka SI, Yamazawa S, Ohnishi K, Woltjen K, Ushiku T, et al. DMRT1-mediated reprogramming drives development of cancer resembling human germ cell tumors with features of totipotency. Nature Communications. 12: 5041. PMID 34413299 DOI: 10.1038/s41467-021-25249-4   
2021 Chen CL, Meng E, Wu ST, Lai HF, Lu YS, Yang MH, Tsao CW, Kao CC, Chiu YL. Targeting May Result in Enhanced Migration of Cancer Cells in Bladder Carcinoma. Cancers. 13. PMID 34503284 DOI: 10.3390/cancers13174474   
2021 Su X, Xu Y, Fox GC, Xiang J, Kwakwa KA, Davis JL, Belle JI, Lee WC, Wong WH, Fontana F, Hernandez-Aya L, Kobayashi T, Tomasson HM, Su J, Bakewell SJ, et al. Breast cancer derived GM-CSF regulates arginase 1 in myeloid cells to promote an immunosuppressive microenvironment. The Journal of Clinical Investigation. PMID 34520398 DOI: 10.1172/JCI145296   
2021 Zhou R, Feng Y, Ye J, Han Z, Liang Y, Chen Q, Xu X, Huang Y, Jia Z, Zhong W. Prediction of Biochemical Recurrence-Free Survival of Prostate Cancer Patients Leveraging Multiple Gene Expression Profiles in Tumor Microenvironment. Frontiers in Oncology. 11: 632571. PMID 34631510 DOI: 10.3389/fonc.2021.632571   
2021 Estaras M, Gonzalez A. Modulation of cell physiology under hypoxia in pancreatic cancer. World Journal of Gastroenterology. 27: 4582-4602. PMID 34366624 DOI: 10.3748/wjg.v27.i28.4582   
2021 Sato A, Rahman NIA, Shimizu A, Ogita H. Cell-to-cell contact-mediated regulation of tumor behavior in the tumor microenvironment. Cancer Science. PMID 34420253 DOI: 10.1111/cas.15114   
2021 Skovgard MS, Hocine HR, Saini JK, Moroz M, Bellis RY, Banerjee S, Morello A, Ponomarev V, Villena-Vargas J, Adusumilli PS. Imaging CAR T-cell kinetics in solid tumors: Translational implications. Molecular Therapy Oncolytics. 22: 355-367. PMID 34553024 DOI: 10.1016/j.omto.2021.06.006   
2021 Wang Y, Li X, Peng S, Hu H, Wang Y, Shao M, Feng G, Liu Y, Bai Y. Single-Cell Analysis Reveals Spatial Heterogeneity of Immune Cells in Lung Adenocarcinoma. Frontiers in Cell and Developmental Biology. 9: 638374. PMID 34513820 DOI: 10.3389/fcell.2021.638374   
2021 Zakir U, Siddiqui NN, Naqvi FU, Khan R. Aberrant STAT1 methylation as a non-invasive biomarker in blood of HCV induced hepatocellular carcinoma. Cancer Biomarkers : Section a of Disease Markers. PMID 34657877 DOI: 10.3233/CBM-210216   
2021 Calaf GM, Crispin LA, Roy D, Aguayo F, Muñoz JP, Bleak TC. Gene Signatures Induced by Ionizing Radiation as Prognostic Tools in an In Vitro Experimental Breast Cancer Model. Cancers. 13. PMID 34572798 DOI: 10.3390/cancers13184571   
2021 Bondoc A, Glaser K, Jin K, Lake C, Cairo S, Geller J, Tiao G, Aronow B. Identification of distinct tumor cell populations and key genetic mechanisms through single cell sequencing in hepatoblastoma. Communications Biology. 4: 1049. PMID 34497364 DOI: 10.1038/s42003-021-02562-8   
2021 Luong N, Lenz JA, Modiano JF, Olson JK. Extracellular Vesicles Secreted by Tumor Cells Promote the Generation of Suppressive Monocytes. Immunohorizons. 5: 647-658. PMID 34404719 DOI: 10.4049/immunohorizons.2000017   
2021 Zhao Y, Hu S, Zhang J, Cai Z, Wang S, Liu M, Dai J, Gao Y. Glucoside xylosyltransferase 2 as a diagnostic and prognostic marker in gastric cancer via comprehensive analysis. Bioengineered. 12: 5641-5654. PMID 34506251 DOI: 10.1080/21655979.2021.1967067   
2021 Ali H, Olsson L, Lindmark G, Hammarström ML, Hammarström S, Sitohy B. The myeloid cell biomarker EMR1 is ectopically expressed in colon cancer. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 43: 209-223. PMID 34486997 DOI: 10.3233/TUB-200082   
2021 Prashant NM, Alomran N, Chen Y, Liu H, Bousounis P, Movassagh M, Edwards N, Horvath A. SCReadCounts: estimation of cell-level SNVs expression from scRNA-seq data. Bmc Genomics. 22: 689. PMID 34551708 DOI: 10.1186/s12864-021-07974-8   
2021 Cheng L, Creasy T, Pilataxi F, Greenlees L, Vence L, Sridhar S, Streicher K. Effects of combination treatment with durvalumab plus tremelimumab on the tumor microenvironment in non-small-cell lung carcinoma. Cancer Immunology, Immunotherapy : Cii. PMID 34623465 DOI: 10.1007/s00262-021-03065-5   
2021 Yoshimatsu Y, Noguchi R, Sin Y, Tsuchiya R, Ono T, Sei A, Sugaya J, Iwata S, Yoshida A, Kawai A, Kondo T. Establishment and characterization of NCC-LGFMS1-C1: a novel patient-derived cell line of low-grade fibromyxoid sarcoma. Human Cell. PMID 34535876 DOI: 10.1007/s13577-021-00612-1   
2021 Eke I, Aryankalayil MJ, Bylicky MA, Sandfort V, Vanpouille-Box C, Nandagopal S, Graves EE, Giaccia AJ, Coleman CN. Long-term expression changes of immune-related genes in prostate cancer after radiotherapy. Cancer Immunology, Immunotherapy : Cii. PMID 34435232 DOI: 10.1007/s00262-021-03036-w   
2021 Jiang M, Chu Y, Yang T, Li W, Zhang Z, Sun H, Liang H, Yang F. Developing a Novel Indium(III) Agent Based on Liposomes to Overcome Cisplatin-Induced Resistance in Breast Cancer by Multitargeting the Tumor Microenvironment Components. Journal of Medicinal Chemistry. PMID 34609868 DOI: 10.1021/acs.jmedchem.1c01068   
2021 Castro J, Tornillo G, Ceada G, Ramos-Neble B, Bravo M, Ribó M, Vilanova M, Smalley MJ, Benito A. A Nuclear-Directed Ribonuclease Variant Targets Cancer Stem Cells and Inhibits Migration and Invasion of Breast Cancer Cells. Cancers. 13. PMID 34503160 DOI: 10.3390/cancers13174350   
2021 Wu SY, Lin KC, Lawal B, Wu ATH, Wu CZ. MXD3 as an onco-immunological biomarker encompassing the tumor microenvironment, disease staging, prognoses, and therapeutic responses in multiple cancer types. Computational and Structural Biotechnology Journal. 19: 4970-4983. PMID 34584637 DOI: 10.1016/j.csbj.2021.08.047   
2021 Hu H, Khodadadi-Jamayran A, Dolgalev I, Cho H, Badri S, Chiriboga LA, Zeck B, Lopez De Rodas Gregorio M, Dowling CM, Labbe K, Deng J, Chen T, Zhang H, Zappile P, Chen Z, et al. Targeting the Atf7ip-Setdb1 complex augments antitumor immunity by boosting tumor immunogenicity. Cancer Immunology Research. PMID 34462284 DOI: 10.1158/2326-6066.CIR-21-0543   
2021 Matsuki M, Hirohashi Y, Nakatsugawa M, Murai A, Kubo T, Hashimoto S, Tokita S, Murata K, Kanaseki T, Tsukahara T, Nishida S, Tanaka T, Kitamura H, Masumori N, Torigoe T. Tumor-infiltrating CD8 T cells recognize a heterogeneously expressed functional neoantigen in clear cell renal cell carcinoma. Cancer Immunology, Immunotherapy : Cii. PMID 34491407 DOI: 10.1007/s00262-021-03048-6   
2021 Synnott NC, Poeta ML, Costantini M, Pfeiffer RM, Li M, Golubeva Y, Lawrence S, Mutreja K, Amoreo C, Dabrowska M, Simone G, Pescarmona E, Lenz P, Olanich M, Duggan M, et al. Characterizing the tumor microenvironment in rare renal cancer histological types. The Journal of Pathology. Clinical Research. PMID 34618413 DOI: 10.1002/cjp2.241   
2021 Bagheri-Yarmand R, Busaidy NL, McBeath E, Danysh BP, Evans KW, Moss TJ, Akcakanat A, Ng PKS, Knippler CM, Golden JA, Williams MD, Multani AS, Cabanillas ME, Shaw KR, Meric-Bernstam F, et al. Alterations Induce Acquired Dabrafenib Resistance in Association with Anaplastic Transformation in a Papillary Thyroid Cancer Patient. Cancers. 13. PMID 34638434 DOI: 10.3390/cancers13194950   
2021 Kopylov AM, Fab LV, Antipova O, Savchenko EA, Revishchin AV, Parshina VV, Pavlova SV, Kireev II, Golovin AV, Usachev DY, Pavlova GV. RNA Aptamers for Theranostics of Glioblastoma of Human Brain. Biochemistry. Biokhimiia. 86: 1012-1024. PMID 34488577 DOI: 10.1134/S0006297921080113   
2021 Gu W, Yang J, Wang Y, Xu J, Wang X, Du F, Hu X, Guo H, Song C, Tao R, Zhang X. Comprehensive identification of alterations in 5 557 Chinese patients with solid tumors by next-generation sequencing. American Journal of Cancer Research. 11: 3893-3906. PMID 34522456   
2021 Xiao P, Chen P, Lang X, An Q, Yang C, Chen S, Wang K, Chen N, Hao Y, Ding J, Li Z, Hu S, Xiao S. Ovarian germ cell tumor/mastocytosis with KIT mutation: a unique clinicopathological entity. Genes, Chromosomes & Cancer. PMID 34553465 DOI: 10.1002/gcc.23000   
2021 Li Y, Jin J, Bai F. Cancer biology deciphered by single-cell transcriptomic sequencing. Protein & Cell. PMID 34405376 DOI: 10.1007/s13238-021-00868-1   
2021 Kanwore K, Kambey PA, Guo XX, Abiola AA, Xia Y, Gao D. Extracellular and Intracellular Factors in Brain Cancer. Frontiers in Cell and Developmental Biology. 9: 699103. PMID 34513834 DOI: 10.3389/fcell.2021.699103   
2021 Zhang L, Li Y, Dai Y, Wang D, Wang X, Cao Y, Liu W, Tao Z. Glycolysis-related gene expression profiling serves as a novel prognosis risk predictor for human hepatocellular carcinoma. Scientific Reports. 11: 18875. PMID 34556750 DOI: 10.1038/s41598-021-98381-2   
2021 Cui X, Qin F, Yu X, Xiao F, Cai G. SCISSOR™: a single-cell inferred site-specific omics resource for tumor microenvironment association study. Nar Cancer. 3: zcab037. PMID 34514416 DOI: 10.1093/narcan/zcab037   
2021 Yu J, Dong XD, Jiao JS, Ji HY, Liu AJ. Antitumor and immunoregulatory activities of a novel polysaccharide from Astragalus membranaceus on S180 tumor-bearing mice. International Journal of Biological Macromolecules. 189: 930-938. PMID 34419546 DOI: 10.1016/j.ijbiomac.2021.08.099   
2021 Iser IC, Beckenkamp LR, Azambuja JH, Rahmeier FL, Bracco PA, Bertoni APS, de Cássia Sant'Anna Alves R, Braganhol E, Xavier LL, da Cruz Fernandes M, Lenz G, Wink MR. Rat Adipose-Derived Stromal Cells (ADSCs) Increases the Glioblastoma Growth and Decreases the Animal Survival. Stem Cell Reviews and Reports. PMID 34403074 DOI: 10.1007/s12015-021-10227-6   
2021 Comba A, Faisal SM, Varela ML, Hollon T, Al-Holou WN, Umemura Y, Nunez FJ, Motsch S, Castro MG, Lowenstein PR. Uncovering Spatiotemporal Heterogeneity of High-Grade Gliomas: From Disease Biology to Therapeutic Implications. Frontiers in Oncology. 11: 703764. PMID 34422657 DOI: 10.3389/fonc.2021.703764   
2021 Gu S, Qian L, Zhang Y, Chen K, Li Y, Wang J, Wang P. Significance of intratumoral infiltration of B cells in cancer immunotherapy: From a single cell perspective. Biochimica Et Biophysica Acta. Reviews On Cancer. 188632. PMID 34626740 DOI: 10.1016/j.bbcan.2021.188632   
2021 Du C, Li SW, Singh SX, Roso K, Sun MA, Pirozzi CJ, Yang R, Li JL, He Y. Epigenetic regulation of Fanconi anemia genes implicates PRMT5 blockage as a strategy for tumor chemosensitization. Molecular Cancer Research : McR. PMID 34521764 DOI: 10.1158/1541-7786.MCR-21-0093   
2021 Gui S, Chen P, Liu Y, Chen Q, Cheng T, Lv S, Zhou T, Song Z, Xiao J, He W, Yuan S, Cheng Z. TUBA1C expression promotes proliferation by regulating the cell cycle and indicates poor prognosis in glioma. Biochemical and Biophysical Research Communications. 577: 130-138. PMID 34517210 DOI: 10.1016/j.bbrc.2021.08.079   
2021 Xia X, Zhang H, Xia P, Zhu Y, Liu J, Xu K, Yuan Y. Identification of Glycolysis-Related lncRNAs and the Novel lncRNA WAC-AS1 Promotes Glycolysis and Tumor Progression in Hepatocellular Carcinoma. Frontiers in Oncology. 11: 733595. PMID 34527595 DOI: 10.3389/fonc.2021.733595   
2021 Foroutan M, Molania R, Pfefferle A, Behrenbruch C, Scheer S, Kallies A, Speed TP, Cursons J, Huntington ND. The Ratio of Exhausted to Resident Infiltrating Lymphocytes Is Prognostic for Colorectal Cancer Patient Outcome. Cancer Immunology Research. PMID 34413087 DOI: 10.1158/2326-6066.CIR-21-0137   
2021 Cheng SM, Liu JL, Chen T, Bi YZ, Liu KY, Wang QY, Tang HX, Yang YH, Zhang XB, Hu RR, Liu SQ, Zhang K, Kong LB, Guo DL, Shu ZF, et al. [Establishment of human colon cancer transplantation tumor model in normal immune mice]. Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]. 43: 939-943. PMID 34530576 DOI: 10.3760/cma.j.cn112152-20190915-00596   
2021 Stoltzfus CR, Sivakumar R, Kunz L, Olin Pope BE, Menietti E, Speziale D, Adelfio R, Bacac M, Colombetti S, Perro M, Gerner MY. Multi-Parameter Quantitative Imaging of Tumor Microenvironments Reveals Perivascular Immune Niches Associated With Anti-Tumor Immunity. Frontiers in Immunology. 12: 726492. PMID 34421928 DOI: 10.3389/fimmu.2021.726492   
2021 Zheng M, Hu Y, Gou R, Li S, Nie X, Li X, Lin B. Development of a seven-gene tumor immune microenvironment prognostic signature for high-risk grade III endometrial cancer. Molecular Therapy Oncolytics. 22: 294-306. PMID 34553020 DOI: 10.1016/j.omto.2021.07.002   
2021 Li G, Guo J, Zheng Y, Ding W, Han Z, Qin L, Mo W, Luo M. CXCR5 guides migration and tumor eradication of anti-EGFR chimeric antigen receptor T cells. Molecular Therapy Oncolytics. 22: 507-517. PMID 34553036 DOI: 10.1016/j.omto.2021.07.003   
2021 Lv J, Wu Y, Li W, Fan H. High Expression of ROMO1 Aggravates the Malignancy of Hepatoblastoma. Journal of Oncology. 2021: 2341719. PMID 34512752 DOI: 10.1155/2021/2341719